Medical Pharma Has Obtained a Notice of Issuance for Its Projected Patent Number 8370172

Los Angeles-based Targeted Medical Pharma has obtained a notice of issuance for its projected patent number 8370172 from the US Patent and Trademark Office (USPTO).

The patent is related to a system and method for submitting claims for a dispensed medication to a patient by point-of-care physicians.

The USPTO said Targeted Medical will receive the patent on 5 February 2013.

Targeted Medical Pharma CEO and chief scientific officer William Shell said, "This patent provides point of care physicians with a powerful tool to bill for medications utilized within their practices."